Niagen Bioscience, Inc.

NAGE

Niagen Bioscience, Inc.

NAGE

Insider Sentiment (TTM):

Last Purchase:2025-11-14Last Sale:2024-12-13Shares Purchased (TTM):4,464.96Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:34,184,467Shares Outstanding:79,917,000Institutional Ownership Pct.:42.77%

Earnings Market Reaction:

Filing Date:2026-05-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Medicinal Chemicals & Botanical Products

DFTX TCNNF CRON TLRY USNA CGC

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Nonrelated Party	-	-	-	-	-	8	-	-	-	5	-1	6
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	67	65	64	60	56	45	32	28	28	27	27	26
Accounts Receivable Net Current	13	10	9	10	7	8	7	8	7	-	-	-
Inventory Gross	24	20	-	-	-	9	-	-	-	-	-	-
Inventory Net	24	-	19	14	11	9	11	12	12	15	13	12
Assets Held For Sale Not Part Of Disposal Group Cu…	0	1	-	-	-	0	-	-	-	-	-	-
Prepaid Expense And Other Assets	1	1	2	2	2	2	2	2	2	2	2	2
Assets Current	105	97	94	87	76	64	52	49	49	50	47	46
Property Plant And Equipment And Finance Lease Rig…	1	1	1	2	2	2	2	2	2	2	2	3
Intangible Assets Net Excluding Goodwill	5	6	0	0	0	0	0	0	0	1	1	1
Operating Lease Right Of Use Asset	2	2	2	3	3	2	2	2	2	2	3	3
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	1
Assets	114	106	98	92	81	68	57	54	54	55	53	53
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	13	11	13	14	11	9	7	8	8	10	9	10
Accrued Liabilities Current	8	8	9	7	9	8	10	9	10	9	9	8
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	1	1	1
Finance Lease Liability Current	-	0	0	0	0	0	0	0	0	0	0	0
Deferred Compensation Liability Current	1	-	-	-	-	-	-	-	-	-	-	-
Deferred Income Current	0	0	0	0	0	1	0	0	0	0	0	0
Liabilities Current	23	20	23	22	21	18	18	18	19	21	19	19
Contract With Customer Liability Noncurrent	3	3	3	3	3	3	3	3	3	3	4	4
Operating Lease Liability Noncurrent	2	2	2	2	3	2	2	2	2	3	3	3
Finance Lease Liability Noncurrent	-	-	-	-	-	0	0	0	0	0	0	0
Deferred Compensation Liability Classified Noncurr…	5	5	-	-	-	0	-	-	-	-	-	-
Liabilities	32	30	27	27	26	22	22	23	25	27	26	26
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	240	241	239	237	232	228	223	222	220	219	218	217
Retained Earnings Accumulated Deficit	-158	-165	-169	-173	-177	-182	-189	-191	-191	-190	-191	-190
Translation Adjustment Functional To Reporting Cur…	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Stockholders Equity	82	77	71	64	55	46	34	31	29	28	27	27
Liabilities And Stockholders Equity	114	106	98	92	81	68	57	54	54	55	53	53
Restricted Cash	0	0	0	0	0	0	0	0	0	0	0	0
Related Party	-	-	-	-	-	0	-2	1	3	3	0	3
Allowance For Doubtful Accounts Receivable Current	0	0	0	0	0	0	0	0	0	0	1	1
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	150	150	150	150	150	150	150	150	150	150	150	150
Common Stock Shares Issued	238	239	239	239	235	232	228	226	225	225	225	225
Shares Outstanding	79	80	80	80	78	77	76	75	75	75	75	75

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-22.33%	-31.19%	-	-	-	-	-	-	-	-	-	-
2025	28.05%	68.28%	10.30%	5.32%	3.83%	-19.47%	-2.59%	-4.46%	-13.53%	-14.98%	-0.20%	-25.91%
2024	-27.94%	-28.72%	-19.84%	31.18%	44.49%	31.94%	113.18%	57.31%	70.20%	20.89%	31.79%	76.43%
2023	3.40%	6.80%	13.61%	-5.45%	-11.52%	-20.00%	-11.88%	-10.63%	-4.38%	100.00%	97.70%	79.31%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	4.61	4.86	4.12	3.88	3.66	3.57	2.95	2.76	2.52	2.40	2.43	2.43
Quick Ratio	3.55	3.83	3.29	3.24	3.12	3.06	2.35	2.12	1.88	1.70	1.78	1.81
Working Capital	82.30M	76.89M	70.90M	64.35M	55.38M	46.15M	34.44M	31.44M	29.52M	28.91M	27.74M	27.32M
Leverage & Debt
Debt to Equity	0.39	0.39	0.39	0.43	0.47	0.48	0.64	0.76	0.87	0.93	0.96	0.96
Interest Coverage TTM	7.15	8.51	9.91	10.04	9.81	6.84	0.40	-2.27	-4.85	-7.70	-16.98	-39.61
Debt Ratio	0.28	0.28	0.28	0.30	0.32	0.32	0.39	0.43	0.46	0.48	0.49	0.49
Efficiency & Turnover
Asset Turnover TTM	1.33	1.48	1.61	1.60	1.59	1.62	1.67	1.60	1.54	1.53	1.68	1.62
Days Sales Outstanding TTM	28.16	24.69	22.83	27.42	23.09	28.47	28.25	33.34	34.73	-	-	-
Receivables Turnover TTM	12.96	14.78	15.99	13.31	15.81	12.82	12.92	10.95	10.51	-	-	-
Per Share Metrics
Diluted EPS TTM	0.22	0.20	0.24	0.21	0.17	0.11	0.02	-0.02	-0.05	-0.07	-0.09	-0.09
Free Cash Flow Per Share TTM	0.06	0.17	0.27	0.27	0.25	0.16	0.05	0.01	0.06	0.09	0.08	0.03
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	64.28%	64.28%	63.89%	63.62%	62.51%	61.84%	61.45%	60.82%	60.98%	60.76%	59.80%	59.42%
Operating Profit Margin TTM	10.03%	12.58%	15.48%	14.33%	12.26%	7.76%	0.49%	-2.69%	-5.24%	-6.70%	-8.25%	-10.86%
Net Profit Margin TTM	14.29%	13.43%	16.38%	15.24%	13.07%	8.58%	1.62%	-1.58%	-4.24%	-5.91%	-7.76%	-8.03%
Growth Metrics
Net Revenue Growth (1Y)	20.84%	29.95%	36.04%	35.89%	29.77%	19.18%	9.95%	5.74%	7.52%	15.99%	21.15%	17.20%
Net Income Growth (1Y)	32.13%	103.30%	1,275.69%	-1,411.32%	-499.80%	-273.15%	-122.95%	-79.19%	-67.03%	-70.15%	-68.36%	-77.06%
EPS Growth (1Y)	28.65%	94.96%	1,210.04%	-1,350.26%	-486.55%	-270.99%	-122.67%	-79.35%	-67.22%	-72.24%	-71.18%	-79.09%
Valuation Metrics
P/E TTM	18.91	28.97	36.44	64.41	38.06	47.16	186.73	-152.57	-74.21	-21.71	-16.94	-18.12
P/B TTM	4.28	6.58	10.53	17.79	9.70	8.75	8.07	6.72	9.04	3.77	4.01	4.34
P/S TTM	2.70	3.89	5.97	9.82	4.97	4.05	3.03	2.41	3.15	1.28	1.31	1.45
Market Cap	352.43M	503.57M	744.34M	1.14B	536.89M	403.18M	277.30M	206.28M	261.80M	107.23M	109.57M	117.70M
Enterprise Value	285.88M	438.78M	680.05M	1.08B	481.28M	358.53M	244.91M	178.41M	234.26M	79.93M	82.82M	91.32M
Calculated Values
Free Cash Flow TTM	4.43M	13.50M	21.41M	21.21M	19.70M	12.11M	4.18M	1.08M	4.62M	7.12M	6.14M	2.00M
Net Debt	-66.55M	-64.79M	-64.29M	-60.47M	-55.61M	-44.65M	-32.38M	-27.87M	-27.55M	-27.30M	-26.75M	-26.38M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-11-14Purchase

Owner: Pamir, Ozan

Title: Chief Financial Officer

Shares: 4,465

Price/Share: $6.81

Value: $30,406.38

Shares Owned: 7,372

Relationship: Officer

Ownership: Direct

2025-03-07Purchase

Owner: Lopez, Carlos Luis

Title: SVP, General Counsel

Shares: 273

Price/Share: $7.86

Value: $2,145.78

Shares Owned: 2,251

Relationship: Officer

Ownership: Direct

2024-12-13Sale

Owner: Jaksch, Frank L Jr

Title: -

Shares: 37,161

Price/Share: $6.19

Value: $230,026.59

Shares Owned: 244,179

Relationship: Director

Ownership: Direct

2024-11-22Purchase

Owner: Pamir, Ozan

Title: Chief Financial Officer

Shares: 2,907

Price/Share: $7.36

Value: $21,396.99

Shares Owned: 2,907

Relationship: Officer

Ownership: Direct

2024-08-23Sale

Owner: Patrick, Kristin

Title: -

Shares: 23,000

Price/Share: $3.57

Value: $82,110.00

Shares Owned: -

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-11-14	Pamir, Ozan	Officer	Chief Financial Officer	Direct	Purchase	4,465	6.81	$30,406.38	7,372	4
2025-03-07	Lopez, Carlos Luis	Officer	SVP, General Counsel	Direct	Purchase	273	7.86	$2,145.78	2,251	4
2024-12-13	Jaksch, Frank L Jr	Director	-	Direct	Sale	37,161	6.19	$230,026.59	244,179	4
2024-11-22	Pamir, Ozan	Officer	Chief Financial Officer	Direct	Purchase	2,907	7.36	$21,396.99	2,907	4
2024-08-23	Patrick, Kristin	Director	-	Direct	Sale	23,000	3.57	$82,110.00	0	4
2024-08-20	Li, Ka Shing, Prime Tech …	TenPercentOwner	-	Indirect	Sale	11,408,715	-	-	0	4
2024-08-20	Winsave, Resources Ltd, C…	TenPercentOwner	-	Indirect	Purchase	11,408,715	-	-	19,294,356	4
2023-12-01	Gerber, Brianna	Officer	Chief Financial Officer	Direct	Purchase	5,000	1.41	$7,050.00	27,436	4
2023-09-06	Champion, River Ventures …	Director,TenPercentOwner	-	Indirect	Purchase	3,467,778	-	-	11,408,715	4
2023-06-12	Jaksch, Frank L Jr	Director	-	Direct	Purchase	7,000	1.69	$11,830.00	231,339	4
2023-05-31	Fried, Robert N	Director,Officer	Chief Executive Officer	Indirect	Purchase	7,000	1.42	$9,940.00	95,001	4
2023-05-25	Rubin, Steven D	Director	-	Direct	Purchase	7,000	1.46	$10,220.00	7,000	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

42.77%

Inst. Shares: 34,184,467

Shares Outstanding: 79,917,000

2025-12-31

37.45%

Inst. Shares: 29,650,216

Shares Outstanding: 79,178,000

2025-09-30

35.91%

Inst. Shares: 28,647,577

Shares Outstanding: 79,779,000

2025-06-30

33.05%

Inst. Shares: 26,192,388

Shares Outstanding: 79,249,000

2025-03-31

28.23%

Inst. Shares: 21,963,998

Shares Outstanding: 77,810,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	34,184,467	79,917,000	42.77%
2025-12-31	29,650,216	79,178,000	37.45%
2025-09-30	28,647,577	79,779,000	35.91%
2025-06-30	26,192,388	79,249,000	33.05%
2025-03-31	21,963,998	77,810,000	28.23%
2024-12-31	19,389,957	75,929,000	25.54%
2024-09-30	14,326,525	75,972,000	18.86%
2024-06-30	13,314,330	75,559,000	17.62%
2024-03-31	9,335,378	75,230,000	12.41%
2023-12-31	7,993,859	74,985,000	10.66%
2023-09-30	8,108,816	75,050,000	10.80%
2023-06-30	7,956,631	74,967,000	10.61%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Niagen Bioscience, Inc. (NAGE) — SEC Financial Statements & Analysis

Niagen Bioscience, Inc. (NAGE) is a medicinal chemicals & botanical products company, incorporated in DE. Niagen Bioscience, Inc. trades on NAGE: Nasdaq as: NAGE. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Niagen Bioscience, Inc. reported a 20.84% year-over-year revenue growth, a Gross Profit Margin of 64.28% (TTM), a Debt-to-Equity ratio of 0.39x, a Price-to-Sales (P/S) ratio of 2.70x (TTM), a Price-to-Book (P/B) ratio of 4.28 (TTM), at a market cap of $352.43M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 20.84%
Gross Profit Margin TTM: 64.28%
Debt To Equity: 0.39x
P/S TTM: 2.70x
P/B TTM: 4.28
Market Cap: $352.43M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Niagen Bioscience, Inc. in?

Niagen Bioscience, Inc. (NAGE) operates in the Medicinal Chemicals & Botanical Products industry.

What is NAGE's market cap?

Niagen Bioscience, Inc. (NAGE) has a market capitalization of $352.43M as of 2026-03-31.

What is NAGE's P/E ratio?

Niagen Bioscience, Inc. (NAGE)'s trailing twelve month P/E ratio is 18.91x as of 2026-03-31.

What exchange does NAGE trade on?

Niagen Bioscience, Inc. (NAGE) trades on the NAGE: Nasdaq.

Where is Niagen Bioscience, Inc. incorporated?

Niagen Bioscience, Inc. is incorporated in DE.

Niagen Bioscience, Inc. (NAGE) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.